Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

651 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor.
Asakura M, Ikegame K, Yoshihara S, Taniguchi S, Mori T, Etoh T, Takami A, Yoshida T, Fukuda T, Hatanaka K, Kanamori H, Yujiri T, Atsuta Y, Sakamaki H, Suzuki R, Ogawa H. Asakura M, et al. Among authors: hatanaka k. Int J Hematol. 2010 Sep;92(2):351-9. doi: 10.1007/s12185-010-0657-y. Epub 2010 Aug 7. Int J Hematol. 2010. PMID: 20694532
Use of mycophenolate mofetil and a calcineurin inhibitor in allogeneic hematopoietic stem-cell transplantation from HLA-matched siblings or unrelated volunteer donors: Japanese multicenter phase II trials.
Nakane T, Nakamae H, Yamaguchi T, Kurosawa S, Okamura A, Hidaka M, Fuji S, Kohno A, Saito T, Aoyama Y, Hatanaka K, Katayama Y, Yakushijin K, Matsui T, Yamamori M, Takami A, Hino M, Fukuda T. Nakane T, et al. Among authors: hatanaka k. Int J Hematol. 2017 Apr;105(4):485-496. doi: 10.1007/s12185-016-2154-4. Epub 2016 Dec 9. Int J Hematol. 2017. PMID: 27943166 Clinical Trial.
Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies.
Kim SW, Matsuo K, Fukuda T, Hara M, Matsue K, Taniguchi S, Eto T, Tanimoto M, Wake A, Hatanaka K, Nakao S, Ishida Y, Harada M, Utsunomiya A, Imamura M, Kanda Y, Sunami K, Kawano F, Takaue Y, Teshima T. Kim SW, et al. Among authors: hatanaka k. Int J Hematol. 2008 Oct;88(3):324-330. doi: 10.1007/s12185-008-0163-7. Epub 2008 Sep 17. Int J Hematol. 2008. PMID: 18797985
Peripheral blood as a preferable source of stem cells for salvage transplantation in patients with graft failure after cord blood transplantation: a retrospective analysis of the registry data of the Japanese Society for Hematopoietic Cell Transplantation.
Fuji S, Nakamura F, Hatanaka K, Taniguchi S, Sato M, Mori S, Sakamaki H, Yabe H, Miyamoto T, Kanamori H, Ueda Y, Kawa K, Kato K, Suzuki R, Atsuta Y, Tamaki T, Kanda Y. Fuji S, et al. Among authors: hatanaka k. Biol Blood Marrow Transplant. 2012 Sep;18(9):1407-14. doi: 10.1016/j.bbmt.2012.02.014. Epub 2012 Mar 16. Biol Blood Marrow Transplant. 2012. PMID: 22430086 Free article.
Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism.
Ichinohe T, Uchiyama T, Shimazaki C, Matsuo K, Tamaki S, Hino M, Watanabe A, Hamaguchi M, Adachi S, Gondo H, Uoshima N, Yoshihara T, Hatanaka K, Fujii H, Kawa K, Kawanishi K, Oka K, Kimura H, Itoh M, Inukai T, Maruya E, Saji H, Kodera Y; Japanese Collaborative Study Group for NIMA-Complementary Haploidentical Stem Cell Transplantation. Ichinohe T, et al. Among authors: hatanaka k. Blood. 2004 Dec 1;104(12):3821-8. doi: 10.1182/blood-2004-03-1212. Epub 2004 Jul 27. Blood. 2004. PMID: 15280193 Free article.
651 results